Menarini Owners Acquitted Of Fraud
Executive Summary
Lucia and Giovanni Aleotti have been cleared of fraud against the Italian health system, and will continue to lead the Florentine company transformed into a major multinational by their father.
You may also be interested in...
Business As Usual For Menarini Despite Managing Siblings’ Fraud Sentence
Siblings Lucia and Alberto Giovanni Aleotti, respectively president and vice-president of Italian pharmaceutical company Menarini, have been sentenced for tax fraud by a court in Florence. Lucia Aleotti has resigned from the board of Farmindustria, Italy’s industry association, but its president Massimo Scaccabarozzi declared his expectation that they would be cleared on appeal. The case is far from closed.
20 Voices: What Does 2024 Hold For Biopharma?
20 executives in the biopharma industry outline their view of key trends this year. A selection of commentary from a broad industry survey by Scrip.
Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances
More than 100 biopharma executives and experts told Scrip their predictions for therapeutic area advances in the coming year. The recent commercial success of GLP-1s in diabetes and obesity and their potential in further disease areas fuelled excitement around the metabolic space. Expectations were also positive in neurology following the launch of Leqembi for Alzheimer’s disease in 2023, while the multiple opportunities to improve cancer treatment kept oncology top of the pile overall.